OTTAWA HEART INSTITUTE RES CORPORATION has a total of 19 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 1994. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, medical technology and pharmaceuticals are BAXTER HEALTHCARE CORP, NEXELL THERAPEUTICS INC and MEYERS RACHEL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Chile | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Medical technology | |
#3 | Pharmaceuticals | |
#4 | Control | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Syringes | |
#5 | Object sterilising | |
#6 | Control or regulating systems | |
#7 | Therapeutic chemical compounds | |
#8 | Analysing materials | |
#9 | Diagnosis and surgery | |
#10 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Dekemp Robert A | 5 |
#2 | Suuronen Erik | 4 |
#3 | Alarcon Emilio | 4 |
#4 | Ruel Marc | 4 |
#5 | Davis Darryl | 3 |
#6 | Courtman David | 2 |
#7 | Mount Seth | 2 |
#8 | Klein Ran | 2 |
#9 | Stewart Duncan J | 2 |
#10 | Robert A Dekemp | 1 |
Publication | Filing date | Title |
---|---|---|
US2020172871A1 | Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereof | |
US2020121847A1 | Infusion Procedure For Enhancing Image Quality | |
US2020147118A1 | Compositions and methods for detection, risk assessment and treatment of diabetes, obesity, and inflammation | |
KR20200046445A | Infusion procedure for enhancing image quality | |
AU2018253543B1 | Infusion procedure for enhancing image quality | |
CA3021925A1 | Infusion procedure for enhancing image quality | |
CA3061156A1 | Biocompatible hydrogel compositions and uses thereof | |
US2018127752A1 | Therapeutics targeting IGFBP7 for the treatment or prevention of heart failure and metabolic diseases | |
US2017340678A1 | Serum-free and xenogen-free human cardiac explant-derived stem cells and uses and methods for the production thereof | |
AU7607494A | Electrohydraulic ventricular assist device |